Lafudin Tablet
Lafutidine
5mg
Alive Pharmaceutical. Pvt. Ltd.
| Pack size | 100's |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 8.00 NPR |
Available as:
Indications
Lafudin Tablet is used for:
Gastric and duodenal ulcers; Stomal ulcers, Gastric mucosal lesions
Adult Dose
Oral
Gastric and duodenal ulcers; Stomal ulcers
Adult: 10 mg bid, once after breakfast, once after evening meal or before sleeping. Adjust dose according to patient's age and symptoms.
Gastric mucosal lesions
Adult: 10 mg once daily, after evening meal or before sleeping. Adjust dose according to patient's age and symptoms.
Pre-anaesthetic medication
Adult: 10 mg before sleeping on the day before operation, and 10 mg 2 hr before introduction of anaesthetic on the day of operation.
Elderly: Dose reduction or increase in dosing interval may be needed.
Hepatic impairment: Dose reduction or increase in dosing interval may be needed.
Child Dose
Renal Dose
Renal impairment: Dose reduction or increase in dosing interval may be needed.
Administration
Contra Indications
Lactation.
Precautions
Hepatic and renal impairment. Elderly.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Lafutidine :
Constipation, hyperuricaemia, increase in LFT and total bilirubin, gynaecomastia, anorexia, hallucinations.
Potentially Fatal: Anaphylactic reactions, blood dyscrasias (e.g. agranulocytosis, thrombocytopenia).
Mechanism of Action
Lafutidine is a histamine H2-antagonist with gastroprotective activity. It is used in the treatment of gastric ulcers and before general anaesthesia to reduce the incidence of aspiration pneumonia.
Note
Lafudin 5mg Tablet manufactured by Alive Pharmaceutical. Pvt. Ltd.. Its generic name is Lafutidine. Lafudin is availble in Nepal.
Farmaco Nepal drug index information on Lafudin Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.